Indefinite Delivery Contract SPE2DR25D9311

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

This IDC is part of DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which seeks to establish multiple regional contracts to provide worldwide pharmaceutical support to the Department of Defense, the U.S. Coast Guard, and other government agencies. The PPV-G GEN V solicitation is expected to be issued in March 2024 with an estimated total value of $30.3 billion. The procurement will be conducted on a Lowest Price Technically Acceptable (LPTA) basis, and the government intends to make at least three regional awards to ensure resiliency in the pharmaceutical supply chain.